activ
avail
cme
credit
see
page
import
inform
asthma
heterogen
disord
character
variabl
airflow
obstruct
airway
inflamm
hyperrespons
revers
either
spontan
result
treatment
multipl
caus
doubt
exist
incept
symptom
exacerb
diseas
establish
factor
underli
incept
rang
viral
respiratori
tract
infect
infanc
occup
exposur
adult
factor
underli
asthma
exacerb
includ
allergen
exposur
sensit
individu
viral
infect
exercis
irrit
ingest
nonsteroid
antiinflammatori
agent
among
other
exacerb
factor
might
includ
one
exposur
vari
among
within
patient
asthma
treatment
determin
larg
extent
assess
sever
variabl
time
assess
domain
impair
current
risk
longterm
consequ
unfortun
despit
avail
effect
therapi
suboptim
asthma
control
exist
mani
patient
worldwid
basi
mani
asthmat
patient
diseas
root
infanc
earli
childhood
viral
respiratori
tract
infect
produc
wheez
episod
first
year
life
children
children
stop
wheez
transient
wheezer
wherea
other
go
persist
symptom
either
dissip
adolesc
primarili
nonatop
individu
continu
adolesc
atop
wheezer
remiss
diseas
process
might
remain
quiescent
individu
could
relaps
later
life
pattern
rate
loss
lung
function
asthmat
subject
interest
concern
mani
investig
number
group
report
greatest
absolut
loss
lung
function
appear
occur
earli
childhood
report
peak
lung
function
achiev
year
age
patient
asthma
might
decreas
rate
loss
adulthood
might
increas
asthmat
subject
one
fourth
children
asthma
could
experi
greater
rate
loss
lung
function
children
certain
phenotyp
characterist
younger
age
male
sex
higher
postbronchodil
fev
percent
predict
greater
airway
eosinophil
inflamm
precis
time
incept
inflammatori
respons
characterist
asthma
unknown
although
recent
biopsi
studi
wheez
infant
document
revers
airflow
obstruct
show
consist
inflammatori
structur
chang
ie
remodel
group
demonstr
increas
number
inflammatori
cell
mediat
wheez
preschool
children
despit
advanc
understand
factor
contribut
mild
persist
asthma
children
potenti
longterm
consequ
much
still
need
learn
risk
factor
relationship
asthma
evalu
context
diseas
incept
eg
viral
infect
environment
exposur
eg
aeroallergen
pollut
tobacco
smoke
lifestyl
eg
live
farm
diet
antibiot
use
comorbid
condit
eg
atop
dermat
obes
occup
exposur
among
other
well
diseas
sever
defin
risk
domain
discuss
subsequ
hospit
frequenc
sever
exacerb
loss
lung
function
genet
factor
also
contribut
significantli
diseas
express
sever
asthma
genet
classifi
complex
disord
follow
simpl
mendelian
inherit
characterist
hundr
genet
associ
studi
asthmarel
phenotyp
conduct
differ
popul
recent
review
although
import
genebyenviron
interact
express
diseas
recent
highlight
complex
involv
analyz
relationship
function
perspect
prove
challeng
recent
pharmacogenet
evalu
relationship
chronic
bagonist
use
corticosteroid
efficaci
provid
new
insight
variabl
respons
asthmat
patient
allergen
allergen
exposur
import
host
allerg
sensit
common
precipit
asthmat
symptom
children
adult
format
antigenspecif
ige
antibodi
aeroallergen
eg
mite
tree
grass
anim
dander
usual
occur
year
life
thu
aeroallergeninduc
asthma
uncommon
first
year
life
begin
increas
preval
later
childhood
adolesc
peak
second
decad
life
establish
genet
predispos
individu
igemedi
reaction
major
contributor
acut
asthmat
symptom
chronic
airway
inflamm
chronic
lowlevel
exposur
indoor
allergen
dust
mite
cockroach
particular
might
play
major
role
asthma
incept
subsequ
provoc
symptom
although
wide
varieti
inhal
allergen
provok
asthma
symptom
sensit
hous
dust
mite
cockroach
alternaria
speci
possibl
cat
import
pathogenesi
asthma
dog
cat
ownership
infanc
shown
reduc
subsequ
develop
allerg
sensit
atop
dermat
number
pet
type
fur
pet
might
also
reduc
futur
risk
divers
find
indic
relationship
inde
complex
might
involv
genebyenviron
interact
pollen
immunotherapi
schoolag
children
allerg
rhiniti
start
treatment
demonstr
reduc
significantli
subsequ
risk
develop
airway
hyperrespons
asthma
infect
respiratori
tract
infect
caus
virus
chlamydia
speci
mycoplasma
speci
implic
pathogenesi
asthma
respiratori
pathogen
virus
demonstr
epidemiolog
associ
asthma
least
way
first
infanc
certain
virus
implic
potenti
respons
incept
asthmat
phenotyp
viru
convincingli
demonstr
regard
respiratori
syncyti
viru
howev
nearli
everi
child
infect
least
viru
year
age
addit
genet
environment
development
factor
must
contribut
propens
particular
viru
epidemiolog
link
childhood
asthma
second
patient
establish
asthma
particularli
children
viral
upper
respiratori
tract
infect
play
signific
role
produc
acut
exacerb
airway
obstruct
might
result
frequent
outpati
visit
hospit
rhinoviru
common
cold
viru
frequent
caus
exacerb
virus
includ
parainfluenza
respiratori
syncyti
viru
influenza
coronaviru
also
implic
albeit
lesser
extent
increas
tendenc
viral
infect
produc
lower
airway
symptom
asthmat
individu
might
relat
least
part
interact
among
allerg
sensit
allergen
exposur
viral
infect
act
cofactor
induct
acut
episod
airflow
obstruct
abnorm
innat
immun
respons
would
prevent
viral
replic
airway
epitheli
cell
asthmat
subject
recent
demonstr
third
paradox
infect
consid
potenti
actual
prevent
develop
allerg
respiratori
tract
diseas
includ
asthma
interest
area
increas
advanc
hygien
hypothesi
propos
increas
famili
size
coincid
increas
number
infect
might
protect
develop
basi
progress
broader
interpret
initi
hypothesi
number
epidemiolog
eg
live
farm
biolog
eg
probiot
factor
evalu
regard
abil
influenc
develop
allerg
sensit
asthma
infect
microbi
agent
recent
attent
focus
chlamydia
speci
mycoplasma
speci
potenti
contributor
exacerb
sever
chronic
asthma
term
loss
lung
function
medic
requir
final
infect
involv
upper
airway
ie
sinus
consid
contribut
asthma
control
instabl
evok
concept
unifi
airway
relationship
inflammatori
respons
alter
airway
physiolog
exercis
exercis
one
common
precipit
airway
obstruct
asthmat
patient
symptom
exerciseinduc
bronchospasm
includ
follow
wheez
cough
short
breath
children
chest
pain
discomfort
symptom
intens
minut
usual
resolv
within
minut
exercis
cessat
circumst
degre
bronchoconstrict
rare
sever
enough
lifethreaten
situat
almost
invari
reflect
advanc
untreat
diseas
confound
trigger
factor
ie
concomit
allergen
irrit
exposur
object
document
airflow
obstruct
exercis
abbrevi
use
gerd
gastroesophag
reflux
diseas
nsaid
nonsteroid
antiinflammatori
drug
challeng
test
decreas
fev
convinc
histori
appropri
respons
prophylact
rescu
medic
requir
make
diagnosi
exerciseinduc
bronchospasm
exercis
challeng
test
must
suffici
intens
durat
abl
accur
diagnos
condit
keep
mind
confound
problem
vocal
cord
dysfunct
might
need
consid
differenti
diagnosi
nonsteroid
antiinflammatori
drug
approxim
adult
asthmat
patient
acut
worsen
symptom
nonsteroid
antiinflammatori
drug
nsaid
aspirin
triadasthma
nasal
polyp
aspirin
sensitivityi
usual
found
adult
asthmat
patient
respons
aspirin
nsaid
begin
within
hour
aspirin
ingest
associ
profound
rhinorrhea
eye
lacrim
potenti
sever
bronchospasm
patient
sensit
aspirin
usual
reactiv
nsaid
variat
frequenc
sever
advers
respons
appear
depend
potenc
drug
within
class
compound
inhibit
activ
enzym
use
inhibitor
aspirinsensit
patient
might
possibl
worthi
consider
sensit
nsaid
ige
mediat
involv
modul
eicosanoid
product
suggest
nsaid
act
reduc
format
prostaglandin
help
maintain
normal
airway
function
increas
format
asthmaprovok
eicosanoid
includ
hydroxyeicosatetraeno
acid
larg
quantiti
cysteinyl
leukotrien
addit
evid
mast
cell
activ
occur
mediat
detect
nasal
secret
episod
aspirininduc
asthma
syndrom
concern
asthmat
patient
nasal
polyposi
chronic
sinus
eosinophilia
although
polyposi
sinus
might
preced
onset
recogn
nsaid
sensit
year
gastroesophag
reflux
true
incid
gastroesophag
reflux
diseas
gerd
asthma
caus
factor
diseas
sever
yet
establish
howev
estim
mani
adult
children
asthma
gerd
mechan
gerd
affect
asthma
also
establish
might
includ
microaspir
irrit
esophagu
reflux
bronchospasm
although
often
asymptomat
present
mani
patient
nighttim
exacerb
difficulttocontrol
symptom
confirm
import
gerd
asthma
often
requir
endoscopi
monitor
intraesophag
ph
level
concomit
measur
peak
expiratori
flow
rate
recognit
factor
asthma
sever
import
effect
therapi
current
avail
psychosoci
factor
role
psychosoci
factor
stress
undergon
import
reevalu
term
diseas
risk
factor
concomit
compon
sever
evid
shown
parent
stress
risk
factor
asthma
express
children
mechan
occur
defin
might
includ
promot
allerg
inflamm
recent
work
demonstr
doseresponsetyp
relationship
panic
asthma
bidirect
longitudin
associ
condit
although
number
research
group
investig
strategi
aim
asthma
prevent
goal
yet
achiev
therefor
therapi
present
direct
primarili
achiev
optim
control
attempt
minim
shortand
longterm
side
effect
therapeut
intervent
asthma
control
defin
understand
patient
asthma
sever
view
domain
impair
risk
impair
evalu
concurr
degre
control
achiev
follow
minim
chronic
symptom
includ
nocturn
awaken
caus
asthma
minim
need
acut
rescu
therapi
inhal
b
agonist
establish
normal
lifestyl
limit
activ
includ
exercis
normal
pulmonari
function
risk
domain
includ
criteria
deal
futur
event
treatment
program
either
prevent
reduc
greatest
extent
possibl
reduct
elimin
frequenc
sever
asthma
exacerb
minim
loss
lung
function
time
consid
potenti
consequ
airway
remodel
minim
advers
effect
medic
select
pharmacolog
treatment
determin
basi
age
patient
sever
asthma
asthma
variabl
chronic
diseas
syndrom
specif
treatment
need
adjust
acut
exacerb
chronic
context
elimin
reduc
impair
risk
dynam
fluctuat
time
stepwis
approach
adapt
treatment
accomplish
goal
see
http
wwwnhlbinihgov
guidelinesasthmaasthsummhtm
basi
stepwis
approach
increas
number
frequenc
dose
medic
increas
asthma
sever
patient
diseas
put
remiss
ie
achiev
optim
control
individu
remiss
establish
stepdown
therapi
attempt
minim
medic
burden
whenev
possibl
last
year
number
publish
clinic
trial
use
new
therapeut
agent
novel
treatment
strategi
noteworthi
basi
potenti
effect
initi
adjust
medic
base
stepwis
sever
scheme
first
trial
perform
asthma
clinic
research
network
demonstr
mild
persist
asthma
low
impair
low
risk
treatment
symptombas
action
plan
daili
control
therapi
suffici
maintain
control
peak
flow
asthma
exacerb
qualiti
life
increas
loss
lung
function
year
treatment
although
monotherapi
inhal
corticosteroid
trial
significantli
improv
prebronchodil
fev
bronchial
reactiv
biomark
airway
inflamm
exhal
nitric
oxid
sputum
eosinophil
symptomfre
day
clinic
relev
chang
open
individu
clinician
interpret
second
preschool
children
histori
consist
asthmalik
symptom
relat
viral
infect
treatment
leukotrien
receptor
antagonist
shown
significantli
reduc
frequenc
type
exacerb
amount
inhal
corticosteroid
use
treat
episod
third
studi
evalu
use
combin
product
contain
inhal
corticosteroid
longact
bagonist
first
trial
guidelinedefin
control
achiev
combin
therapi
fluticason
plu
salmeterol
signific
proport
patient
use
escal
dose
reach
outcom
second
trial
singl
inhal
contain
combin
product
budesonid
plu
formoterol
use
daili
control
rescu
medic
compar
higherdos
monotherapi
budesonid
shortact
bagonist
rescu
combin
product
shortact
bagonist
rescu
reduct
frequenc
exacerb
treatment
period
significantli
greater
combin
therapi
use
daili
control
therapi
rescu
medic
fourth
therapi
guid
physiolog
variabl
biomark
airway
hyperrespons
sputum
eosinophil
count
exhal
nitric
oxid
level
might
provid
new
direct
improv
asthma
manag
final
therapi
global
select
modul
immunoinflammatori
network
use
antiig
mab
allergenderiv
peptid
modifi
recombin
allergen
vaccin
immunostimulatori
dna
sequenc
among
other
offer
novel
therapeut
strategi
futur
asthma
complex
genet
disord
character
airway
inflamm
revers
airflow
obstruct
distinguish
multipl
phenotyp
might
differ
basi
age
onset
trigger
factor
pattern
sever
acut
exacerb
chronic
basi
reflect
variabl
revers
loss
lung
function
result
clinic
heterogen
treatment
approach
need
individu
modifi
obtain
maintain
adequ
symptom
diseas
control
time
although
current
therapi
target
develop
secondari
tertiari
prevent
strategi
ongo
research
evalu
prospect
primari
prevent
well
